HSBC Holdings
MRVI icon

HSBC Holdings’s Maravai LifeSciences MRVI Stock Holding History

HSBC Holdings’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,763
Closed -$29.2K – 3161
2025
Q1 		$29.2K Sell
12,763
-84
-0.7% -$332 ﹤0.01% 2951
2024
Q4 		$69K Sell
12,847
-3,567
-22% -$22.9K ﹤0.01% 2950
2024
Q3 		$136K Buy
+16,414
New +$142K ﹤0.01% 2734
2021
Q2 		– Sell
-7,006
Closed -$246K – 3021
2021
Q1 		$246K Sell
7,006
-4,835
-41% -$160K ﹤0.01% 2427
2020
Q4 		$333K Buy
+11,841
New +$330K ﹤0.01% 2497

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HSBC Holdings's MRVI Position: Q2 2025 in Review

HSBC Holdings sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 12,763 shares — an estimated $29.2K sold.

HSBC Holdings first reported a position in MRVI in Q4 2020 and held it in 5 quarters. The position peaked at $333K in Q4 2020. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • HSBC Holdings reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 12,763 Maravai LifeSciences shares in Q2 2025, an estimated $29.2K.
  • HSBC Holdings first reported a position in Maravai LifeSciences in Q4 2020 and held it in 5 quarters.
  • HSBC Holdings's Maravai LifeSciences position peaked at $333K in Q4 2020.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.